Company profile
HLB Group company profile
HLB Group creates a management network to establish the conditions for the manufacture, sale, and discovery of new medications. They create rivoceranib, the cancer medicine, and "UNITE," a platform for the next generation of immunotherapy vaccines against cancer and allergies.
Business identity
- Website
- http://www.hlbkorea.com
- Contact email
- [email protected]
- Phone number
- 82-52-240-3500
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 101-250 employees
- Revenue range
- $1M-$10M
- Founded
- 1985-01-01
Headquarters
- Headquarters
- Ulsan, Ulsan, South Korea
- Postal code
- 216-53
- Country code
- KR
- Continent
- Asia